Family Life and HIV Education (FLHE) programme was introduced nationwide in Nigeria in 2003. Since then little is known about the patterns of its implementation across the states in the six geo-political zones in Nigeria.

In December 2013, ministers of education and health from twenty ESA countries affirmed and endorsed their joint commitment to deliver comprehensive sexuality

HIV/AIDS is one of the most important public health challenges facing Nigeria today. Recent evidence has revealed that the adolescent population make up a large proportion of the 3.7% reported prevalence rate among Nigerians aged 15–49 years.

This initiative brings together policy makers, young people and civil society to strengthen sexuality education and reproductive and sexual health services in eastern and southern Africa.

This collaborative regional curriculum scan, which was conducted in 2011, seeks to assess the content, quality, and delivery methods of sexuality education curricula in ten ESA countries and aims to ensure that the reviews help countries to develop curricula designed to not only increase comprehe

This report examines the findings of an external assessment of the A+ programme, an innovative IPPF youth-led programme funded by Danida. The A+ programme was implemented by IPPF’s Member Associations in 16 countries across Sub-Saharan Africa, South Asia and Central America.

The Learning about Living (LaL) Nigeria project was initially piloted in Lagos and Cross River States, and the Federal Capital Territory Abuja, from 2007 to 2009 and coordinated by OneWorld UK (OWUK).

The ability of specific behaviour-change interventions to reduce HIV infection in young people remains questionable.

Schools have been identified as one of the appropriate settings for addiction prevention since this is the place where pupils may come into contact with drugs for the first time and experiment with them, with the possibility of becoming addicted.

The Global Initiative on Primary Prevention of Substance Abuse (Global Initiative) is jointly executed by the United Nations International Drug Control Programme (UNDCP) and the World Health Organization (WHO). Implementation began in June 1997.